Acute Leukemia, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Author :
By Martin S. Tallman, MD
Topics for this issue will include: CLL: A Historical Perspective; Incidence & Epidemiology; Biology, Molecular Biology & Cytogenetics of CLL; What does the status of smatic hypermutations in IGVH genes tell us about the origin of CLL?; What
...view more
Topics for this issue will include: CLL: A Historical Perspective; Incidence & Epidemiology; Biology, Molecular Biology & Cytogenetics of CLL; What does the status of smatic hypermutations in IGVH genes tell us about the origin of CLL?; What does the status of ZAP-70 tell us about the biology of CLL?; and Approach to initial therapy: When to start therapy?
Topics for this issue will include: CLL: A Historical Perspective; Incidence & Epidemiology; Biology, Molecular Biology & Cytogenetics of CLL; What does the status of smatic hypermutations in IGVH genes tell us about the origin of CLL?; What does the status of ZAP-70 tell us about the biology of CLL?; and Approach to initial therapy: When to start therapy?
Author Information
By Martin S. Tallman, MD, Chief, Leukemia Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, NY
By Martin S. Tallman, MD, Chief, Leukemia Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, NY
https://www.asia.elsevierhealth.com/acute-leukemia-an-issue-of-hematologyoncology-clinics-of-north-america-9781455711970.html299965Acute Leukemia, An Issue of Hematology/Oncology Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9781455711970_8.jpg74.2498.99USDInStock/Clinics/Medicine & Surgery/Hematology/Medicine/Hematology/Clinics/Clinics/Medicine/Hematology/Japan Titles43887254431214505462250546665255041525991152631601418269243350884886536505455351451205259833Topics for this issue will include: CLL: A Historical Perspective; Incidence & Epidemiology; Biology, Molecular Biology & Cytogenetics of CLL; What does the status of smatic hypermutations in IGVH genes tell us about the origin of CLL?; What does the status of ZAP-70 tell us about the biology of CLL?; and Approach to initial therapy: When to start therapy? Topics for this issue will include: CLL: A Historical Perspective; Incidence & Epidemiology; Biology, Molecular Biology & Cytogenetics of CLL; What does the status of smatic hypermutations in IGVH genes tell us about the origin of CLL?; What does the status of ZAP-70 tell us about the biology of CLL?; and Approach to initial therapy: When to start therapy?00add-to-cart97814557119702011 and earlierProfessionalBy Martin S. Tallman, MD20111Book152w x 229h (6.00" x 9.00")Saunders0Dec 15, 2011IN STOCKBy <STRONG>Martin S. Tallman</STRONG>, MD, Chief, Leukemia Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, NYClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
